Specialty pharmaceutical company Cumberland Pharmaceuticals (Nasdaq: CPIX) today announced the publication of new real-world outcomes research demonstrating the safety and healthcare resource ...

Pharmaceuticals announced the publication of new real-world outcomes research demonstrating the safety and healthcare ...

The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) ...

Joanne F. Shen, MD, director of the dry eye clinic at Mayo Clinic's campus in Phoenix, Arizona, and a research team studied 35 patients treated with IPL/MGX. The team reviewed demographics, ocular ...

Dropless cataract surgery eliminates postoperative eye drops, enhancing patient adherence and reducing complications like ...

Dr. Chani Traube, the Gerald M. Loughlin, MD Professor of Pediatrics at Weill Cornell Medicine, has been awarded a $3.4 million grant, with the possibility of extending to a total of $17 million over ...

The US Food and Drug Administration has approved a new oral antibiotic for treatment of uncomplicated urinary tract ...

Use tabs only as continuation therapy to inj. Do not exceed 5 days' combined (inj + tabs) therapy or recommended dose (may use as-needed opioids for breakthrough pain if appropriate). After inj ...

Asplund told police he takes over-the-counter medications Nyquil, Tylenol and melatonin and a prescription analgesic ...

The driver of a pickup truck pleaded not guilty Thursday to charges that he was under the influence of drugs when his vehicle ...

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company ...

Ketorolac is a non-steroidal anti-inflammatory agent (NSAID), prescribed for short-term management of severe pain, usually after surgery that requires analgesia (pain killer) at the opioid level ...